[{"Assets_0_Q3_USD":1079246000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":134690310.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":137025698.0,"StockholdersEquity_0_Q3_USD":969942000.0,"RevenuesConverted_3_Q3_USD":38438000.0,"RevenuesConverted_1_Q3_USD":49000.0,"NetIncomeLossConverted_3_Q3_USD":-182137000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":137025698.0,"NetIncomeLossConverted_1_Q3_USD":-78186000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.35,"EarningsPerShareDiluted_1_Q3_USD":-0.57,"EarningsPerShareBasic_3_Q3_USD":-1.35,"EarningsPerShareBasic_1_Q3_USD":-0.57,"CommonStockSharesOutstanding_0_Q3_shares":142439829.0,"CommonStockSharesConverted_0_Q3_shares":142439829.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-139376000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":134690310.0,"Ticker":"ALLO","CIK":"1737287","name":"ALLOGENE THERAPEUTICS, INC.","OfficialName":"Allogene Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1134878416.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]